This inventor holds 1 USPTO granted patent. Top assignee: Universite Paris Cité. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Xavier Gerard in Retinal Dystrophies Treatment
Introduction
Xavier Gerard is an accomplished inventor based in Lausanne, Switzerland. He has made significant contributions to the field of medical science, particularly in the treatment of retinal dystrophies. His innovative approach has garnered attention in the scientific community.
Latest Patents
Xavier Gerard holds a patent titled "Methods for the Treatment of Retinal Dystrophies by Exon-Skipping Strategy." This patent represents a breakthrough in therapeutic strategies aimed at addressing retinal disorders, showcasing his commitment to advancing medical treatments.
Career Highlights
Xavier Gerard is affiliated with Université Paris Cité, where he continues to engage in research and development. His work focuses on innovative solutions that can potentially improve the quality of life for individuals suffering from retinal conditions.
Collaborations
Xavier collaborates with notable colleagues, including Jean-Michel Rozet and Iris Barny. Their combined expertise enhances the research efforts and contributes to the advancement of their shared goals in medical innovation.
Conclusion
Xavier Gerard's contributions to the treatment of retinal dystrophies through his patented methods highlight his role as a leading inventor in the medical field. His work continues to inspire advancements in therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile